In non-small cell lung cancer, silencing HOXC13 counteracts HOXC-AS2 overexpression-induced increases in cell proliferation and migration and decreases in cell apoptosis [32]. The gene discussed is HOXC13; the disease is non-small cell lung carcinoma.